IN2015DN00837A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00837A
IN2015DN00837A IN837DEN2015A IN2015DN00837A IN 2015DN00837 A IN2015DN00837 A IN 2015DN00837A IN 837DEN2015 A IN837DEN2015 A IN 837DEN2015A IN 2015DN00837 A IN2015DN00837 A IN 2015DN00837A
Authority
IN
India
Prior art keywords
compounds
optionally substituted
hydrogen atom
methods
substituted alkyl
Prior art date
Application number
Inventor
Jon Erik Braenden
Colin Barry Charnock
Aslak Godal
Jo Klaveness
Nils Olav Nilsen
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of IN2015DN00837A publication Critical patent/IN2015DN00837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA

Abstract

The invention relates to new derivatives of 5-aminolevulinic acid (5-ALA) and their use as photosensitizing agents. In particular, it relates to compounds of general formula I and their pharmaceutically acceptable salts, to methods for preparing such compounds and their medical and cosmetic use, for example in methods of photodynamic therapy and diagnosis: wherein R 1 represents a hydrogen atom or an optionally substituted alkyl or cycloalkyl group; R2, each of which may be the same or different, represents a hydrogen atom or an optionally substituted alkyl group; and X is a linking group.
IN837DEN2015 2012-08-03 2013-08-02 IN2015DN00837A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12179277 2012-08-03
EP12197305 2012-12-14
PCT/EP2013/066317 WO2014020164A1 (en) 2012-08-03 2013-08-02 Compounds

Publications (1)

Publication Number Publication Date
IN2015DN00837A true IN2015DN00837A (en) 2015-06-12

Family

ID=48948407

Family Applications (1)

Application Number Title Priority Date Filing Date
IN837DEN2015 IN2015DN00837A (en) 2012-08-03 2013-08-02

Country Status (19)

Country Link
US (1) US9249086B2 (en)
EP (1) EP2880012B1 (en)
JP (1) JP6280117B2 (en)
KR (1) KR102180174B1 (en)
CN (1) CN104661994B (en)
AU (1) AU2013298525B2 (en)
BR (1) BR112015002390B1 (en)
CA (1) CA2880422C (en)
CL (1) CL2015000233A1 (en)
ES (1) ES2908080T3 (en)
HK (1) HK1211283A1 (en)
IL (1) IL236965B (en)
IN (1) IN2015DN00837A (en)
MX (1) MX364940B (en)
NZ (1) NZ629914A (en)
RU (1) RU2635563C2 (en)
SG (1) SG11201500805VA (en)
WO (1) WO2014020164A1 (en)
ZA (1) ZA201500778B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6595484B2 (en) 2013-12-20 2019-10-23 ガルデルマ・リサーチ・アンド・デヴェロップメント Pulsed photodynamic treatment of photodamaged skin
EP3353145B1 (en) * 2015-09-23 2022-09-28 XWPharma Ltd. Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
KR20180094986A (en) * 2015-12-17 2018-08-24 포토큐어 에이에스에이 Methods of photodynamic therapy (PDT) for bladder cancer
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN106187793A (en) * 2016-01-26 2016-12-07 赵鸣 5 aminolevulinic acids and the salt compound of derivant thereof and application
FI3641882T3 (en) * 2017-06-21 2023-12-14 Photocure Asa Method for preparing a liquid pharmaceutical composition and device for use in such method
EP4349401A1 (en) 2019-02-13 2024-04-10 Alpheus Medical, Inc. Non-invasive sonodynamic therapy

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188133A (en) 1993-12-27 1995-07-25 Asahi Chem Ind Co Ltd Production of delta-aminolevulinic acid or its homologue
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
CZ291132B6 (en) * 1995-03-10 2002-12-11 Photocure Asa Esters of 5-aminolevullinic acids and pharmaceutical preparation in which the esters are comprised
JPH1112197A (en) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk Malignant tumor diagnostic agent and therapeutic agent
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
DE10202487A1 (en) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermal application system for aminolevulinic acid derivatives
DE10312659A1 (en) 2003-03-21 2004-10-07 Universität Regensburg New 5-aminolevulinic acid derivatives useful for photodynamic tumor therapy and/or diagnosis
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
CN1942430B (en) * 2004-03-30 2011-04-20 克斯莫石油株式会社 5-aminolevulinic acid phosphate, method for producing the same and use thereof
JP4417865B2 (en) 2004-03-30 2010-02-17 コスモ石油株式会社 5-Aminolevulinic acid phosphate, method for producing the same, and use thereof
JP4719483B2 (en) 2004-03-30 2011-07-06 コスモ石油株式会社 Process for producing 5-aminolevulinic acid sulfonate
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
JP5404995B2 (en) 2006-08-10 2014-02-05 コスモ石油株式会社 Plant polyphenol extender
JP5039389B2 (en) 2007-02-02 2012-10-03 コスモ石油株式会社 Hop alpha acid or hop oil content improver
ES2550243T3 (en) 2007-03-30 2015-11-05 Cosmo Ala Co., Ltd. Agent to improve the alkali resistance of a plant and method to improve the alkali resistance of a plant
JP4705616B2 (en) 2007-07-20 2011-06-22 コスモ石油株式会社 Absorption enhancer of metal components in plants
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
EP2231105A1 (en) * 2007-12-14 2010-09-29 Photoderma SA Novel compounds useful in therapeutic and cosmetic methods
CA2721042C (en) 2008-04-22 2017-07-11 Sbi Alapromo Co., Ltd. Method of detecting bladder cancer
EP2274979B8 (en) 2008-05-13 2016-10-12 COSMO TRaDE & SERVICE CO., LTD. Agent for improving lawn grass qualities
JP5276894B2 (en) 2008-05-13 2013-08-28 コスモ石油株式会社 Rice seedling raising improver
JP5323539B2 (en) 2009-03-11 2013-10-23 コスモ石油株式会社 Yield improver for crop crops

Also Published As

Publication number Publication date
SG11201500805VA (en) 2015-02-27
WO2014020164A1 (en) 2014-02-06
US20150191419A1 (en) 2015-07-09
KR102180174B1 (en) 2020-11-19
CA2880422A1 (en) 2014-02-06
HK1211283A1 (en) 2016-05-20
CA2880422C (en) 2021-02-09
KR20150039208A (en) 2015-04-09
CN104661994B (en) 2017-08-08
AU2013298525B2 (en) 2017-12-14
IL236965B (en) 2019-03-31
JP2015528814A (en) 2015-10-01
BR112015002390A2 (en) 2017-07-04
US9249086B2 (en) 2016-02-02
BR112015002390B1 (en) 2020-03-24
ZA201500778B (en) 2016-04-28
EP2880012A1 (en) 2015-06-10
JP6280117B2 (en) 2018-02-14
RU2635563C2 (en) 2017-11-14
EP2880012B1 (en) 2021-12-15
CL2015000233A1 (en) 2015-04-24
CN104661994A (en) 2015-05-27
MX2015001374A (en) 2015-09-07
ES2908080T3 (en) 2022-04-27
AU2013298525A1 (en) 2015-03-05
NZ629914A (en) 2017-02-24
MX364940B (en) 2019-05-15
BR112015002390A8 (en) 2019-07-30
RU2015104830A (en) 2016-09-27

Similar Documents

Publication Publication Date Title
IN2015DN00837A (en)
CY1124882T1 (en) 1,4-DI-CONSTITUTED PYRIDAZINE ANALOGUES AND METHODS FOR THERAPEUTIC TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY
EA201490647A1 (en) DERIVATIVES OF BENZOTHIAZOL-6-LUCUS ACID AND THEIR APPLICATION FOR THE TREATMENT OF HIV INFECTION
BR112015001502A2 (en) azaindazole or diazaindazole derivatives for pain management
NZ739760A (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
DOP2014000204A (en) HETEROCICLYL COMPOUNDS AS MEK INHIBITORS
CR20130023A (en) PIRAZOLO [1,5-A] PYRIMIDINS FOR ANTIVIRAL TREATMENT
BR112015009395A2 (en) process for preparation of bile acid derivatives
NZ627274A (en) Anesthetic compounds and related methods of use
NZ703989A (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
MX342924B (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases.
EA201792071A3 (en) GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION
NZ603465A (en) Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
PH12015502429A1 (en) Dicarboxylic acid compound
MX2013008340A (en) Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer.
TR201902057T4 (en) Tetracycline compounds.
GB201209587D0 (en) Therapeutic compounds
PH12015500012B1 (en) Benzodioxole derivative and preparation method and use thereof
MX2013002620A (en) Novel n-hydroxy-benzamides for the treatment of cancer.
MX345264B (en) Azole derivative.
RU2014123690A (en) THERAPEUTIC FOR ARTHROSIS
MX2013006670A (en) 2-carboxamide-4-piperazinyl-benzofuran derivative.
BR112015032180A2 (en) method of preparing pyrrolidine-2-carboxylic acid derivatives
DOP2012000061A (en) USE OF INDOL DERIVATIVES AS ACTIVATORS OF NURR-1, FOR THE APPLICATION IN TREATMENTS OF DISEASES AS PARKINSON